Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-03.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89 Ectopic Fat Assessment Focusing on Cardiometabolic and Renal Risk
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Endocrinol Metab > Volume 29(1); 2014 > Article
Namgok Lecture 2013
Ectopic Fat Assessment Focusing on Cardiometabolic and Renal Risk
Soo Lim
Endocrinology and Metabolism 2014;29(1):1-4.
DOI: https://doi.org/10.3803/EnM.2014.29.1.1
Published online: March 14, 2014

Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Corresponding author: Soo Lim. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea. Tel: +82-31-787-7035, Fax: +82-31-787-4052, limsoo@snu.ac.kr

Copyright © 2014 Korean Endocrine Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 3,717 Views
  • 58 Download
  • 36 Web of Science
  • 36 Crossref
  • 34 Scopus
  • It is well known that people with high levels of body fat are at higher risk for developing diabetes mellitus, kidney disease, and cardiovascular disorders. Since individuals who are slightly overweight, or even individuals of normal weight, can vary in body fat distribution, their metabolic profiles and the degree of association of these profiles with cardiometabolic risk factors may differ. Fat distribution might be more of a predictive factor for cardiorenometabolic risk than obesity itself, which has led researchers to investigate whether ectopic fat accumulation may partially account for the development of cardiorenometabolic disorders. In addition to visceral obesity, fat can accumulate in the liver and muscle, and these intrahepatic and intramuscular lipid stores are associated with insulin resistance and adverse metabolic phenotypes. More recently, pericardial fat, perivascular fat, and perirenal fat were found to be associated with coronary atherosclerosis, cardiovascular diseases, and kidney damage, respectively. Thus, regional fat distribution may play a key role in understanding the development of cardiorenometabolic diseases in nonobese people.
Obesity and its complications have been increasing worldwide and are becoming big burdensome to both healthcare costs and mortality. Obesity, particularly when accompanied by an excess of visceral or ectopic fat, is a major risk factor for diseases, including insulin resistance, type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease [1]. In addition to overall obesity, ectopic fat and fat accumulation in specific compartments of the body have been found to detrimentally contribute to various health conditions. Ectopic fat is defined as fat depots in various organs or tissues, including fat in the liver and muscle, pericardial and perivascular fat, and fat around the kidney. Fat depots in the liver or muscle tissue can increase adverse cardiometabolic risk by affecting systemic energy metabolism. Pericardial fat, perivascular fat, and renal sinus fat may exert their primary effects on adjacent anatomic organs by direct lipotoxicity, and they act indirectly by cytokine secretion. Additionally, pericardial fat is known to be associated with coronary atherosclerosis. Perivascular fat may play an independent role in adverse vascular biology, contributing to arterial stiffness. Renal sinus fat is a unique fat depot that may confer additional cardiometabolic risk such as high blood pressure. Thus, exploring ectopic fat depots may contribute to understanding the link between body composition and cardiometabolic risk.
In that this article, we investigated the clinical implications of ectopic fat depots from a cardiorenometabolic perspective, and we assessed the imaging techniques used to measure the fat depots.
Fatty liver contributes to cardiometabolic risk in several ways [2]. For example, fat deposition in the liver induces hepatic insulin resistance and also stimulates the production of inflam-matory cytokines [3]. Additionally, fat depots in the liver induce hepatic very low density lipoprotein production through apolipoprotein B metabolism and de novo lipogenesis [4]. These findings support a significant association between fat accumulation in the liver and systemic inflammation and atherogenesis.
Classically, ultrasonography has been used to define fatty liver, but it is limited by its lack of discrete quantification [5]. Conversely, computed tomography (CT) is used to evaluate fat accumulation in the liver qualitatively and quantitatively, but CT carries the risk of radiation exposure [6]. Recently, a noninvasive method, volume-localized 1H-magnetic resonance spectroscopy (MRS), was established [7], which offers the unique ability to measure intrahepatic lipid content in vivo. However, this approach is limited by cost due to the required specialized machinery.
Skeletal muscle tissue is the main destination for insulin-stimulated glucose disposal and is considered to be a principal determinant of systemic insulin resistance [8]. One potential mechanism to explain the relationship between intramuscular lipid and insulin resistance is the apparent defects in fatty acid metabolism in people with high intramuscular fat [9]. Specifically, defects in the fatty acid oxidation pathway lead to diminished use of fatty acids and increased esterification and lipid storage within skeletal muscle. These impairments in fatty acid metabolism result in metabolic abnormalities. Thus, derangements in fatty acid and triglyceride metabolism during fat accumulation in skeletal muscle contribute to cardiovascular risk.
As noninvasive methods, dual-energy X-ray absorptiometry (DXA) and CT have been used to measure fat deposition in muscle [10,11]. The advantage that DXA offers is its ability to measure upper and lower extremity fat amount separately with a single scan image. CT technique can indirectly estimate the degree of fat content in the muscle by measuring the Hounsfield unit range [12]. Recently, another noninvasive method, volume-localized 1H-MRS, was established, and this method offers exquisite discrimination of fat deposition, with the ability to differentiate between intramyocellular and extramyocellular fat deposits in muscle tissue [7].
Fat depots around the heart and coronary arteries can be classified into the following three categories: 1) pericardial fat, which is the fat located between the internal border of the mediastinum and the external surface of the parietal pericardium; 2) epicardial fat or fat tissue within the pericardial sac, mainly in the atrioventricular and interventricular grooves; and 3) pericoronary fat surrounding the coronary arteries within the visceral epicardium. Pericardial fat may have direct effects on the pathogenesis of coronary atherosclerosis through a paracrine role [13]. Specifically, the adipocytokines released from pericardial fat may increase vessel wall inflammation and may stimulate the progression of atherosclerosis via outside-to-inside signaling [14].
By using transthoracic echocardiography, epicardial fat thickness can be measured on the free wall of the right ventricle from parasternal views [15]. Compared to echocardiography, multidetector CT is volumetric, and three-dimensional reconstruction is possible [16]. Also, CT has an advantage in its reproducibility of the quantification of pericardial fat volume. In addition to these methods, the amount of epicardial fat can also be measured in consecutive short-axis views by magnetic resonance imaging (MRI) using the three-dimensional summation of slices method [17].
Vasocrine signaling from perivascular fat was proposed to have a vasoregulatory role in local deposits of fat around the arterioles supplying skeletal muscle [14]. Perivascular fat may possibly contribute to insulin resistance through direct vascular effects leading to reduced capillary cross-sectional area in the muscle, which, in turn, affects muscular blood flow and glucose uptake. Since perivascular adipose tissue expresses cytokines that stimulate inflammation and inhibit insulin signaling pathways, perivascular fat induces impairment of endothelium-dependent vasodilatation and leads to vascular complications [14,18]. Thus, perivascular fat might contribute to the development and progression of atherosclerosis.
Perivascular adipose tissue can be measured by multidetector CT and MRI. In a study using multidetector CT, abdominal periaortic adipose tissue was defined by a 5-mm cylindrical region of interest around the aortic wall [19]. Additionally, high-resolution MRI can quantify perivascular fat around arteries [20].
Fat accumulation in and around the kidney may also play a distinct role in renal function and blood pressure [21]. In an obese animal model, increased renal sinus fat was associated with increases in blood pressure and renal interstitial pressure through the compression of vessels exiting the kidney [22]. In another animal mode, lipid accumulation within the renal parenchyma induced lipotoxicity, inflammation, oxidative stress, and renal fibrosis [23]. These studies support the association of renal lipid accumulation with concomitant structural and functional changes in the kidney and vasculature.
Renal sinus fat accumulation can be measured from a single-slice area measurement of the kidney by using multidetector CT [24]. Pararenal and perirenal fat thickness can be measured from the inner side of the abdominal musculature to the surface of the kidney by ultrasonography [25].
The present article summarized the evidence regarding the metabolic correlates of ectopic fat depots. Potential mechanisms for the association between body fat distribution and cardiorenometabolic disorders were reviewed. Collectively, current evidence has led to the hypothesis that ectopic fat may partially contribute to cardiorenometabolic disorders. Further investigation to identify additional benefit of targeting fat depots at specific locations in individuals with the greater risk is intriguing. Also, prospective studies focusing on ectopic fat accumulation with cardiorenometabolic events are warranted.

Namgok Award is the highest scientific award by the Korean Endocrine Society and honors to an individual who has excellently contributed to the progress in the field of endocrinology and metabolism. Namgok Award is named after the pen name of Professor Hunki Min, who has founded the Korean Endocrine Society in 1982.

Dr. Soo Lim has received Namgok Award at Autumn Symposium of the Korean Endocrine Society in Nov, 2013.

No potential conflict of interest relevant to this article was reported.

  • 1. Lim S, Despres JP, Koh KK. Prevention of atherosclerosis in overweight/obese patients: in need of novel multi-targeted approaches. Circ J 2011;75:1019–1027. ArticlePubMed
  • 2. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ, Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010;51:1979–1987. ArticlePubMedPMC
  • 3. Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, McCaughan GW, Gorrell MD, Yue DK, Twigg SM. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol 2011;55:435–444. ArticlePubMed
  • 4. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009;42:1331–1346. ArticlePubMed
  • 5. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005;54:3541–3546. ArticlePubMed
  • 6. Qayyum A, Chen DM, Breiman RS, Westphalen AC, Yeh BM, Jones KD, Lu Y, Coakley FV, Callen PW. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 2009;33:110–115. ArticlePubMedPMC
  • 7. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664–671. ArticlePubMedPMC
  • 8. Phillips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 1996;45:947–950. ArticlePubMed
  • 9. Kelley DE, Goodpaster BH. Skeletal muscle triglyceride: an aspect of regional adiposity and insulin resistance. Diabetes Care 2001;24:933–941. ArticlePubMed
  • 10. Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, De Rekeneire N, Kanaya AM, Newman AB, Tylavsky FA, Seidell JC. Health ABC Study. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat: the Health ABC Study. Diabetologia 2005;48:301–308. ArticlePubMedPDF
  • 11. Hansen RD, Williamson DA, Finnegan TP, Lloyd BD, Grady JN, Diamond TH, Smith EU, Stavrinos TM, Thompson MW, Gwinn TH, Allen BJ, Smerdely PI, Diwan AD, Singh NA, Singh MA. Estimation of thigh muscle cross-sectional area by dual-energy X-ray absorptiometry in frail elderly patients. Am J Clin Nutr 2007;86:952–958. ArticlePubMedPDF
  • 12. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 2000;71:885–892. ArticlePubMedPDF
  • 13. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008;117:605–613. ArticlePubMed
  • 14. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005;365:1817–1820. ArticlePubMed
  • 15. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304–310. ArticlePubMed
  • 16. Kim TH, Yu SH, Choi SH, Yoon JW, Kang SM, Chun EJ, Choi SI, Shin H, Lee HK, Park KS, Jang HC, Lim S. Pericardial fat amount is an independent risk factor of coronary artery stenosis assessed by multidetector-row computed tomography: the Korean Atherosclerosis Study 2. Obesity (Silver Spring) 2011;19:1028–1034. ArticlePubMed
  • 17. Fluchter S, Haghi D, Dinter D, Heberlein W, Kuhl HP, Neff W, Sueselbeck T, Borggrefe M, Papavassiliu T. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring) 2007;15:870–878. ArticlePubMed
  • 18. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005;25:2594–2599. ArticlePubMed
  • 19. Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O'Donnell CJ, Fox CS, Hoffmann U. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes (Lond) 2009;33:226–232. ArticlePubMedPMCPDF
  • 20. Rittig K, Staib K, Machann J, Bottcher M, Peter A, Schick F, Claussen C, Stefan N, Fritsche A, Haring HU, Balletshofer B. Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia 2008;51:2093–2099. ArticlePubMedPDF
  • 21. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 2010;56:901–906. ArticlePubMedPMC
  • 22. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 2004;28(Suppl 4):S58–S65. ArticlePubMedPDF
  • 23. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am 2009;93:733–751. ArticlePubMed
  • 24. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS. Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol 2011;12:52ArticlePubMedPMCPDF
  • 25. Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L, Cignarelli M. Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant 2011;26:892–898. ArticlePubMedPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Renal stiffness measured by shear wave elastography and its relationship with perirenal fat in patients with chronic kidney disease
      Yiming Li, Yongzhan Liu, Lili Gao, Chuan Tian
      Journal of Clinical Ultrasound.2024; 52(1): 3.     CrossRef
    • Characterization of Green and Yellow Papaya (Carica papaya) for Anti-Diabetic Activity in Liver and Myoblast Cells and Wound-Healing Activity in Fibroblast Cells
      Haiwen Li, Obaid Ullah Beg, Ahmed Reza Rafie, Sadia Kanwal, Alexandra Ovalle-Cisneros, Milton Omar Faison, Rafat Ali Siddiqui
      Nutrients.2023; 15(8): 1929.     CrossRef
    • Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study
      Goh Eun Chung, Kyungdo Han, Kyu-Na Lee, Jung Ho Bae, Sun Young Yang, Su-Yeon Choi, Jeong Yoon Yim, Nam Ju Heo
      Diabetes & Metabolism.2023; 49(4): 101454.     CrossRef
    • Perirenal Fat as a New Independent Prognostic Factor in Patients With Surgically Treated Clear Cell Renal Cell Carcinoma
      Yiqing Du, Wenbo Yang, Huixin Liu, Caipeng Qin, Xu Tang, Tao Xu
      Clinical Genitourinary Cancer.2022; 20(1): e75.     CrossRef
    • The Influence of Obesity and Metabolic Health on Vascular Health
      Eun-Jung Rhee
      Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
    • Obesity‐related glomerulopathy: Current approaches and future perspectives
      José Ignacio Martínez‐Montoro, Enrique Morales, Isabel Cornejo‐Pareja, Francisco J. Tinahones, José Carlos Fernández‐García
      Obesity Reviews.2022;[Epub]     CrossRef
    • Neck circumference and waist circumference associated with cardiovascular events in type 2 diabetes (Beijing Community Diabetes Study 23)
      Guang-Ran Yang, Ming-Xia Yuan, Gang Wan, Xue-Lian Zhang, Han-Jing Fu, Shen-Yuan Yuan, Liang-Xiang Zhu, Rong-Rong Xie, Jian-Dong Zhang, Yu-Ling Li, Yan-Hua Sun, Qin-Fang Dai, Da-Yong Gao, Xue-Li Cui, Jian-Qin Gao, Zi-Ming Wang, Ying-Jun Chen, Yong-Jin Li,
      Scientific Reports.2021;[Epub]     CrossRef
    • LKB1 Regulates Goat Intramuscular Adipogenesis Through Focal Adhesion Pathway
      Yan Xiong, Yuxue Wang, Qing Xu, An Li, Yongqi Yue, Yan Ma, Yaqiu Lin
      Frontiers in Physiology.2021;[Epub]     CrossRef
    • Serum Uric Acid and Diabetes: From Pathophysiology to Cardiovascular Disease
      Niki Katsiki, George D. Dimitriadis, Dimitri P. Mikhailidis
      Current Pharmaceutical Design.2021; 27(16): 1941.     CrossRef
    • Is Epidural Fat Affected by Peripheric or Visceral Adipose Tissue? A Radiologic View
      Nilüfer AYLANÇ, Mustafa REŞORLU, Gürhan ADAM
      Konuralp Tıp Dergisi.2019; 11(1): 41.     CrossRef
    • Perirenal Adiposity and Other Excessive Intra- and Peri-Organ Fat Depots: What Is the Connection?
      Niki Katsiki, George Dimitriadis, Dimitri P. Mikhailidis
      Angiology.2019; 70(7): 581.     CrossRef
    • Letter: Association of Z-Score of the Log-Transformed A Body Shape Index with Cardiovascular Disease in People Who Are Obese but Metabolically Healthy: The Korea National Health and Nutrition Examination Survey 2007-2010 (J Obes Metab Syndr 2018;27:158-65
      Eun-Jung Rhee
      Journal of Obesity & Metabolic Syndrome.2019; 28(2): 139.     CrossRef
    • Determinants of Bone Mass and Insulin Resistance in Korean Postmenopausal Women: Muscle Area, Strength, or Composition?
      Hye-Sun Park, Jung Soo Lim, Sung-Kil Lim
      Yonsei Medical Journal.2019; 60(8): 742.     CrossRef
    • FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
      Yuya Seko, Kohta Yano, Aya Takahashi, Shinya Okishio, Seita Kataoka, Keiichiroh Okuda, Naoki Mizuno, Masashi Takemura, Hiroyoshi Taketani, Atsushi Umemura, Taichiro Nishikawa, Kanji Yamaguchi, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh
      International Journal of Molecular Sciences.2019; 21(1): 171.     CrossRef
    • Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
      Eun-Jung Rhee
      Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
    • The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study
      Ji Cheol Bae, Ji Min Han, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sam Kwon, Sung-Woo Park, Eun Jung Rhee
      Diabetes Research and Clinical Practice.2018; 135: 1.     CrossRef
    • Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial
      Hila Zelicha, Dan Schwarzfuchs, Ilan Shelef, Yftach Gepner, Gal Tsaban, Lilac Tene, Anat Yaskolka Meir, Avital Bilitzky, Oded Komy, Noa Cohen, Nitzan Bril, Michal Rein, Dana Serfaty, Shira Kenigsbuch, Yoash Chassidim, Benjamin Sarusi, Joachim Thiery, Uta
      Clinical Nutrition.2018; 37(4): 1145.     CrossRef
    • Association between abdominal obesity and increased risk for the development of hypertension regardless of physical activity: A nationwide population‐based study
      Eun‐Jung Rhee, Jung‐Hwan Cho, Hyemi Kwon, Se‐Eun Park, Jin‐Hyung Jung, Kyung‐Do Han, Yong‐Gyu Park, Hye Soon Park, Yang‐Hyun Kim, Soon‐Jib Yoo, Won‐Young Lee
      The Journal of Clinical Hypertension.2018; 20(10): 1417.     CrossRef
    • Mesenchymal stem cells in obesity: insights for translational applications
      Kenichi Matsushita, Victor J Dzau
      Laboratory Investigation.2017; 97(10): 1158.     CrossRef
    • Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome
      Ji Cheol Bae, Soo Kyoung Kim, Ji Min Han, Sam Kwon, Da Young Lee, Jihyun Kim, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun Jung Rhee
      Diabetes Research and Clinical Practice.2017; 129: 136.     CrossRef
    • Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study
      Dong Hyun Sinn, Danbee Kang, Hye Ryoun Jang, Seonhye Gu, Soo Jin Cho, Seung Woon Paik, Seungho Ryu, Yoosoo Chang, Mariana Lazo, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
      Journal of Hepatology.2017; 67(6): 1274.     CrossRef
    • Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications
      Kenichi Matsushita
      Stem Cells International.2016; 2016: 1.     CrossRef
    • LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort
      Ji Cheol Bae, Ji Min Han, Sam Kwon, Jae Hwan Jee, Tae Yang Yu, Moon Kyu Lee, Jae Hyeon Kim
      Atherosclerosis.2016; 251: 170.     CrossRef
    • Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells
      Ying Hui Li, Dae Hee Choi, Eun Hye Lee, Su Ryeon Seo, Seungkoo Lee, Eun-Hee Cho
      Journal of Biological Chemistry.2016; 291(19): 10277.     CrossRef
    • Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signaling
      Kenichi Matsushita, Yaojiong Wu, Richard E Pratt, Victor J Dzau
      Laboratory Investigation.2016; 96(8): 909.     CrossRef
    • Increased risk of subclinical atherosclerosis associated with high visceral adiposity index in apparently healthy Korean adults: the Kangbuk Samsung Health Study
      Hye-Jeong Park, Jihyun Kim, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
      Annals of Medicine.2016; 48(6): 410.     CrossRef
    • The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction
      Yea Eun Kang, Ji Min Kim, Kyong Hye Joung, Ju Hee Lee, Bo Ram You, Min Jeong Choi, Min Jeong Ryu, Young Bok Ko, Min A. Lee, Junguee Lee, Bon Jeong Ku, Minho Shong, Ki Hwan Lee, Hyun Jin Kim, Guillermo López Lluch
      PLOS ONE.2016; 11(4): e0154003.     CrossRef
    • Neck circumference and future cardiovascular events in a high-risk population—A prospective cohort study
      Yingnan Dai, Xiaojing Wan, Xin Li, Enze Jin, Xueqi Li
      Lipids in Health and Disease.2016;[Epub]     CrossRef
    • Anti-obesity Effects of Ethanolic Extract of Polygonatum sibiricum Rhizome in High-fat Diet-fed Mice
      Jong-Hee Ko, Woo-Jin Jeon, Hyuk-Sang Kwon, Seung-Woo Yeon, Jae-Hoon Kang
      Korean Journal of Food Science and Technology.2015; 47(4): 499.     CrossRef
    • Articles in 'Endocrinology and Metabolism' in 2014
      Won-Young Lee
      Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
    • Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance
      Kyoung Min Kim, Kuy-Sook Lee, Gha Young Lee, Hyunjin Jin, Eunice Sung Durrance, Ho Seon Park, Sung Hee Choi, Kyong Soo Park, Young-Bum Kim, Hak Chul Jang, Soo Lim
      Molecular and Cellular Endocrinology.2015; 409: 1.     CrossRef
    • Effects ofPolygonatum sibiricumrhizome ethanol extract in high-fat diet-fed mice
      Jong-Hee Ko, Hyuk-Sang Kwon, Jong-Min Yoon, Jong-Su Yoo, Hyeon-Soo Jang, Ji-Young Kim, Seung-Woo Yeon, Jae-Hoon Kang
      Pharmaceutical Biology.2015; 53(4): 563.     CrossRef
    • Lactisole inhibits the glucose-sensing receptor T1R3 expressed in mouse pancreatic β-cells
      Kunihisa Hamano, Yuko Nakagawa, Yoshiaki Ohtsu, Longfei Li, Johan Medina, Yuji Tanaka, Katsuyoshi Masuda, Mitsuhisa Komatsu, Itaru Kojima
      Journal of Endocrinology.2015; 226(1): 57.     CrossRef
    • Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial
      Ji Cheol Bae, Won Young Lee, Kun Ho Yoon, Joong Yeol Park, Hyun Sik Son, Kyung Ah Han, Kwan Woo Lee, Jeong Taek Woo, Young Cheol Ju, Won Jae Lee, Yoon Young Cho, Moon-Kyu Lee
      Diabetes Care.2015; 38(7): 1245.     CrossRef
    • Letter: The Risk Factors of Sarcopenia among Korean Elderly Men: Based on 2009 Korean National Health and Nutrition Examination Survey Data (Korean J Obes 2014;23:23-31)
      Ho Cheol Hong
      The Korean Journal of Obesity.2014; 23(2): 136.     CrossRef
    • The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes
      Mee Kyoung Kim, Hyun Ji Chun, Jin Hee Park, Dong Myung Yeo, Ki-Hyun Baek, Ki-Ho Song, Dong Jin Chung, Hyuk-Sang Kwon
      Diabetes Research and Clinical Practice.2014; 106(3): 590.     CrossRef

    • PubReader PubReader
    • Cite
      CITE
      export Copy
      Close
    • XML DownloadXML Download

    Endocrinol Metab : Endocrinology and Metabolism